Medicines Substances Companies Statistics

A free, open platform for EU medicines data, based on official EMA data.

Database

Medicines
Substances
Companies

Data Sources

EMA

2026 uMedical - Open Source Project

Imprint
Privacy Policy
Terms
Contact

Ghryvelin (previously Macimorelin Aeterna Zentaris)

Authorised

Human

Details

EMA number	EMEA/H/C/004660
ATC code	V04CD06
Authorisation	11 January 2019
Revision	5

Therapeutic indication

This medicinal product is for diagnostic use only. GHRYVELIN is indicated for the diagnosis of growth hormone deficiency (GHD) in adults.

MeSH: Diagnostic Techniques, Endocrine

Group: macimorelin

Special characteristics

Additional monitoring

Active substances

macimorelin acetate

Marketing Authorisation Holder

Atnahs Pharma Netherlands B.V.

Timeline

Filter by authority:

Ghryvelin (previously Macimorelin Aeterna Zentaris) authorised

11 Jan 2019

authorisedregulatory

Ghryvelin (previously Macimorelin Aeterna Zentaris) | uMedical